SPTBN1

Chr 2AD

spectrin beta, non-erythrocytic 1

Also known as: DDISBA, ELF, HEL102, SPTB2, betaSpII

Spectrin beta chain, non-erythrocytic 1 is an actin crosslinking and molecular scaffold protein that links the plasma membrane to the actin cytoskeleton and plays a critical role in central nervous system development and function. Mutations cause autosomal dominant developmental delay with impaired speech and behavioral abnormalities. This gene is extremely intolerant to loss-of-function variants (pLI ~1.0), indicating that even single pathogenic variants can cause disease.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismADLOEUF 0.091 OMIM phenotype
Clinical SummarySPTBN1
🧬
Gene-Disease Validity (ClinGen)
developmental delay, impaired speech, and behavioral abnormalities · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
47 unique Pathogenic / Likely Pathogenic· 438 VUS of 630 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint
0.09LOEUF
pLI 1.000
Z-score 9.70
OE 0.04 (0.020.09)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint
4.54Z-score
OE missense 0.66 (0.620.70)
931 obs / 1411.2 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.04 (0.020.09)
00.351.4
Missense OE0.66 (0.620.70)
00.61.4
Synonymous OE1.18
01.21.6
LoF obs/exp: 5 / 119.4Missense obs/exp: 931 / 1411.2Syn Z: -3.44
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveSPTBN1-related developmental disorderLOFAD
DN
0.4785th %ile
GOF
0.6930th %ile
LOF
0.55top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF62% of P/LP variants are LoF · LOEUF 0.09
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

630 submitted variants in ClinVar

Classification Summary

Pathogenic20
Likely Pathogenic27
VUS438
Likely Benign81
Benign10
Conflicting3
20
Pathogenic
27
Likely Pathogenic
438
VUS
81
Likely Benign
10
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
12
1
7
0
20
Likely Pathogenic
17
9
1
0
27
VUS
12
410
14
2
438
Likely Benign
0
33
5
43
81
Benign
0
1
2
7
10
Conflicting
3
Total414542952579

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

SPTBN1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗